Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Repair Protein Expression in Canine Cutaneous Mast Cell Tumors
Cutaneous mast cell tumors (MCTs) are common canine neoplasms. Some dog breeds more frequently develop MCTs, suggesting a genetically mediated predisposition. In humans, the most common inherited cancer predisposition is caused by germline defects in the mismatch repair (MMR) genes. Is the same true for dogs?

The objective of this study was to investigate whether inherited defects in the MMR genes predispose some dogs to MCT development, MMR expression in 22 MCTs from young and predisposed breed dogs was compared with MMR expression in 22 MCTs from old dogs of non-MCT-predisposed breeds. MMR expression was investigated immunohistochemically using antibodies against MLH1, MSH2, and MSH6.

Mast cells within all MCTs expressed MLH1, MSH2, and MSH6.

There were no significant differences in the intensity of immunoreactivity or the percentage of cells expressing MMR proteins between MCTs from the 2 groups of dogs.

There were no significant differences in MMR protein expression between grade II and grade III MCTs. These results do not support the hypothesis that inherited MMR defects predispose some dogs to MCT development.


Source: J. S. Munday, A. F. French, I. R. Gibson and K. Gwynne (2009): Widespread Mismatch In: Vet Pathol 46:227-232 (2009)




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Corneal grafting to treat dogs with full-thickness corneal defects members
In some cases, corneal grafting is indicated to treat full-thickness wounds of the cornea. This recently online published study describes corneal grafting for the treatment of full-thickness corneal defects in dogs and - very relevant! - determines its effectiveness in preserving vision.

  • Differentiation between IBD and lymphoma in endoscopic duodenal biopsies from catsmembers
  • Pectinate ligament dysplasia in the Welsh springer spaniel - prevalence and progressionmembers
  • Treatment of limbal melanoma with surgical debulking plus diode lasermembers
  • New Insights in the Canine Adrenal Cortexmembers
  • Maropitant in the treatment of canine chronic bronchitismembers
  • Novel technique to place feeding tubes in small animalsmembers
  • Use of a Surgical Safety Checklistmembers
  • NGAL in dogs with chronic kidney diseasemembers
  • Long-term Outcome of Irish Wolfhound Dogs with different heart medicationsmembers
  • Simple technique for autotransfusion in dogsmembers
  • General anesthesia with an injectable 8% v/v sevoflurane lipid emulsion in dogsmembers
  • Carboplatin sustained-release delivery system in dogs with cancermembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved